| Ticker |
Owner |
Relationship |
Date |
Transaction |
Cost  |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jun 05 | Option Exercise | 3.45 | 15,000 | 51,750 | 111,763 | Jun 09 05:26 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jun 05 | Sale | 12.29 | 15,000 | 184,394 | 96,763 | Jun 09 05:26 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | May 05 | Option Exercise | 3.45 | 15,000 | 51,750 | 110,376 | May 05 07:26 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | May 05 | Sale | 12.29 | 15,000 | 184,298 | 95,376 | May 05 07:26 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 06 | Option Exercise | 3.45 | 15,000 | 51,750 | 110,376 | Apr 08 07:06 PM |
|
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 06 | Sale | 14.94 | 15,000 | 224,172 | 95,376 | Apr 08 07:06 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 05 | Option Exercise | 3.45 | 15,000 | 51,750 | 110,376 | Mar 06 06:49 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 05 | Sale | 18.29 | 15,000 | 274,282 | 95,376 | Mar 06 06:49 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 05 | Option Exercise | 6.10 | 15,000 | 91,509 | 110,376 | Feb 06 07:50 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 05 | Sale | 12.93 | 15,000 | 193,950 | 95,376 | Feb 06 07:50 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 05 | Option Exercise | 6.82 | 15,000 | 102,300 | 110,376 | Jan 06 07:24 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 05 | Sale | 15.19 | 15,000 | 227,854 | 95,376 | Jan 06 07:24 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 05 | Option Exercise | 6.82 | 15,000 | 102,300 | 112,856 | Dec 09 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 05 | Sale | 11.21 | 15,000 | 168,196 | 97,856 | Dec 09 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 05 | Option Exercise | 5.59 | 15,000 | 83,877 | 112,856 | Nov 07 08:00 PM |
|
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 05 | Sale | 11.35 | 15,000 | 170,258 | 97,856 | Nov 07 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 06 | Option Exercise | 4.11 | 15,000 | 61,650 | 111,579 | Oct 08 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 06 | Sale | 10.72 | 15,000 | 160,864 | 96,579 | Oct 08 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 05 | Option Exercise | 4.11 | 15,000 | 61,650 | 111,579 | Sep 05 09:45 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 05 | Sale | 12.20 | 15,000 | 183,072 | 96,579 | Sep 05 09:45 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 05 | Option Exercise | 4.11 | 13,202 | 54,260 | 111,579 | Aug 05 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 05 | Sale | 12.99 | 15,000 | 194,846 | 96,579 | Aug 05 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 28 | Option Exercise | 3.68 | 15,000 | 55,230 | 110,015 | Apr 30 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 26 | Option Exercise | 3.68 | 15,000 | 55,230 | 110,015 | Mar 28 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 26 | Sale | 18.65 | 15,000 | 279,695 | 97,015 | Mar 28 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 26 | Option Exercise | 3.68 | 15,000 | 55,230 | 110,015 | Feb 28 08:01 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 26 | Sale | 19.72 | 15,000 | 295,752 | 97,015 | Feb 28 08:01 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 27 | Option Exercise | 3.68 | 15,000 | 55,230 | 110,015 | Jan 29 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 27 | Sale | 18.58 | 15,000 | 278,729 | 97,015 | Jan 29 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 26 | Option Exercise | 3.68 | 15,000 | 55,230 | 110,015 | Dec 30 08:00 PM |
|
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 26 | Sale | 14.37 | 15,000 | 215,477 | 97,015 | Dec 30 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 26 | Option Exercise | 3.90 | 15,000 | 58,570 | 100,798 | Nov 29 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 26 | Sale | 11.83 | 15,000 | 177,378 | 88,798 | Nov 29 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 28 | Option Exercise | 3.90 | 15,000 | 58,570 | 98,798 | Oct 30 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 28 | Sale | 10.39 | 15,000 | 155,780 | 86,798 | Oct 30 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 26 | Option Exercise | 3.90 | 15,000 | 58,570 | 96,798 | Sep 30 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 26 | Sale | 10.57 | 15,000 | 158,574 | 84,798 | Sep 30 08:00 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 26 | Option Exercise | 3.84 | 13,000 | 49,930 | 97,798 | Aug 28 08:01 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 26 | Sale | 10.04 | 15,000 | 150,606 | 84,798 | Aug 28 08:01 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 26 | Option Exercise | 3.84 | 13,000 | 49,930 | 99,798 | Jul 30 04:20 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 26 | Sale | 10.09 | 15,000 | 151,308 | 86,798 | Jul 30 04:20 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | May 28 | Option Exercise | 3.61 | 15,000 | 54,150 | 103,798 | May 30 04:31 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | May 28 | Sale | 8.32 | 15,000 | 124,818 | 88,798 | May 30 04:31 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 26 | Option Exercise | 3.61 | 15,000 | 54,150 | 103,798 | Apr 29 06:16 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 26 | Sale | 10.72 | 15,000 | 160,746 | 88,798 | Apr 29 06:16 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 26 | Option Exercise | 3.61 | 15,000 | 54,150 | 103,798 | Mar 28 05:44 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 26 | Sale | 9.18 | 15,000 | 137,724 | 88,798 | Mar 28 05:44 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 26 | Option Exercise | 3.61 | 15,000 | 54,150 | 103,798 | Feb 28 06:15 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 26 | Sale | 8.64 | 15,000 | 129,600 | 88,798 | Feb 28 06:15 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 28 | Option Exercise | 3.61 | 15,000 | 54,150 | 103,798 | Jan 30 04:17 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 28 | Sale | 9.68 | 15,000 | 145,158 | 88,798 | Jan 30 04:17 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 26 | Option Exercise | 3.61 | 15,000 | 54,150 | 103,798 | Dec 28 04:06 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 26 | Sale | 5.92 | 17,000 | 100,718 | 88,798 | Dec 28 04:06 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 27 | Option Exercise | 3.61 | 15,000 | 54,150 | 70,798 | Nov 28 07:35 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 27 | Sale | 5.60 | 15,000 | 84,000 | 55,798 | Nov 28 07:35 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 26 | Sale | 5.33 | 4,736 | 25,232 | 55,798 | Nov 28 07:35 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 26 | Sale | 5.70 | 20,000 | 113,935 | 58,534 | Oct 29 09:53 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 15 | Sale | 5.66 | 5,000 | 28,283 | 63,534 | Oct 17 05:58 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 05 | Option Exercise | 3.61 | 15,000 | 54,150 | 83,534 | Sep 06 05:51 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 05 | Sale | 5.60 | 15,000 | 84,000 | 68,534 | Sep 06 05:51 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 27 | Sale | 5.18 | 5,000 | 25,903 | 68,534 | Aug 29 07:07 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 27 | Option Exercise | 3.61 | 15,000 | 54,150 | 88,534 | Jul 30 04:58 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 27 | Sale | 5.60 | 15,000 | 84,000 | 73,534 | Jul 30 04:58 PM |
| SGMO | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 26 | Sale | 5.06 | 5,000 | 25,320 | 73,534 | Jul 30 04:58 PM |
